Serum Ghrelin in Polycystic Ovary Syndrome

NCT02087410 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2014-03-14

No results posted yet for this study

Summary

measuring serum gherlin in polycystic ovary syndrome patients and compare it to healthy levels

Conditions

  • Polycystic Ovary

Sponsors & Collaborators

  • amr hesham el etreby

    lead OTHER

Principal Investigators

  • amr eletrby, MBBCH · ain shams universty maternity hospital

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-10-31
Completion
2014-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02087410 on ClinicalTrials.gov